POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION

POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION

Show other versions (1)

Aim. To study effect of the bone metabolism modulator strontium ranelate on bone mineral density (BMD) and to evaluate it pleiotropic effects on cardiovascular remodeling in women with postmenopausal osteoporosis (PO) and a arterial hypertension (HT).Material and methods. 45 women with PO, HT (1-2 s...

Full description

Bibliographic Details
Main Authors: N. J. Hozjainova, V. M. Tsareva, T. V. Brook, M. S. Bezaltynnyh
Format: Article
Language:English
Published: Столичная издательская компания 2016-01-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
strontium ranelate
postmenopausal osteoporosis
arterial hypertension
cardiovascular remodeling
Online Access:https://www.rpcardio.online/jour/article/view/614

Internet

https://www.rpcardio.online/jour/article/view/614

Similar Items